Beijing : China-made COVID-19 vaccine, CoronaVac is said to be very effective and have strong antibody response among children and adolescents aged between 3 to 17 years, according to a study published in The Lancet Infectious Diseases journal. According to the information received 96 percent of the adolescent and children's have taken two doses of the vaccine, manufactured by Sinovac
Let us tell you that the reactions were mild onky but it has been seen that there were pain around the injected spot. Ragarding the vaccine Qiang Gao Sinovac Life Sciences,China said, "Children and adolescents with COVID-19 usually have mild or asymptomatic infections compared with adults. However, a small number may still be at risk of severe illness".
"They can also transmit the virus to others, making it vital to test the safety and effectiveness of COVID-19 vaccines in younger age groups," Gao said.
Between October 31 and December 2, 2020, 72 children's and adolescents were enrolled in phase 1, and 480 participants enrolled in phase 2 between December 12 and December 30, 2020. But it has been seen among the 550 participants who received first dose of vaccine had advere reactions within 28 days.
Reliance inks agreement to invest USD1.5 bn in Abu Dhabi petrochemical hub
White House Announcement: Joe Biden to visit Florida after condo collapse
Moderna claims its Covid-19 vaccine protective against newly detected Delta variants